<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rmt</journal-id><journal-title-group><journal-title xml:lang="ru">Общая реаниматология</journal-title><trans-title-group xml:lang="en"><trans-title>General Reanimatology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-9779</issn><issn pub-type="epub">2411-7110</issn><publisher><publisher-name>FSBI "SRIGR" RAMS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15360/1813-9779-2021-2-27-36</article-id><article-id custom-type="elpub" pub-id-type="custom">rmt-2050</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ И ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL AND EXPERIMENTAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Аортокоронарное шунтирование у пациента с пароксизмальной ночной гемоглобинурией (клиническое наблюдение)</article-title><trans-title-group xml:lang="en"><trans-title>Coronary Artery By-Pass Grafting in Patient With Paroxysmal Nocturnal Hemoglobinuria (Case Report)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Амендола</surname><given-names>А.</given-names></name><name name-style="western" xml:lang="en"><surname>Amendola</surname><given-names>A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>85100, Потенца, ул. Виа Потито Петроне.</p></bio><bio xml:lang="en"><p>Angela Amendola.</p><p>Via Potito Pttrone, 85100 Potenza.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Патерностер</surname><given-names>Дж.</given-names></name><name name-style="western" xml:lang="en"><surname>Paternoster</surname><given-names>G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Джанлука Патерностер.</p><p>85100, Потенца, ул. Виа Потито Петроне.</p></bio><bio xml:lang="en"><p>Gianluca Paternoster.</p><p>Via Potito Pttrone, 85100 Potenza.</p></bio><email xlink:type="simple">paternostergianluca@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Паскале</surname><given-names>С. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Pascale</surname><given-names>S. P</given-names></name></name-alternatives><bio xml:lang="ru"><p>85100, Потенца, ул. Виа Потито Петроне.</p></bio><bio xml:lang="en"><p>Sara Pasquina Pascale.</p><p>Via Potito Pttrone, 85100 Potenza.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нуккорини</surname><given-names>Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Nuccorini</surname><given-names>R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>85100, Потенца, ул. Виа Потито Петроне.</p></bio><bio xml:lang="en"><p>Roberta Nuccorini.</p><p>Via Potito Pttrone, 85100 Potenza.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Д'Амора</surname><given-names>М.</given-names></name><name name-style="western" xml:lang="en"><surname>D'Amora</surname><given-names>M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>85100, Потенца, ул. Виа Потито Петроне.</p></bio><bio xml:lang="en"><p>Mauro D'Amora.</p><p>Via Potito Pttrone, 85100 Potenza.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Питтелла</surname><given-names>Дж.</given-names></name><name name-style="western" xml:lang="en"><surname>Pittella</surname><given-names>G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>85100, Потенца, ул. Виа Потито Петроне.</p></bio><bio xml:lang="en"><p>Giuseppe Pittella.</p><p>Via Potito Pttrone, 85100 Potenza.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Д'Асколи</surname><given-names>Р.</given-names></name><name name-style="western" xml:lang="en"><surname>D'Ascoli</surname><given-names>R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>85100, Потенца, ул. Виа Потито Петроне.</p></bio><bio xml:lang="en"><p>Riccardo D'Ascoli.</p><p>Via Potito Pttrone, 85100 Potenza.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Престипино</surname><given-names>Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Prestipino</surname><given-names>F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>85100, Потенца, ул. Виа Потито Петроне.</p></bio><bio xml:lang="en"><p>Filippo Prestipino.</p><p>Via Potito Pttrone, 85100 Potenza.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Луци</surname><given-names>Дж.</given-names></name><name name-style="western" xml:lang="en"><surname>Luzi</surname><given-names>G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>85100, Потенца, ул. Виа Потито Петроне.</p></bio><bio xml:lang="en"><p>Giampaolo Luzi.</p><p>Via Potito Pttrone, 85100 Potenza.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пиццути</surname><given-names>М.</given-names></name><name name-style="western" xml:lang="en"><surname>Pizzuti</surname><given-names>M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>85100, Потенца, ул. Виа Потито Петроне.</p></bio><bio xml:lang="en"><p>Michele Pizzuti.</p><p>Via Potito Pttrone, 85100 Potenza.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Центр гематологии и трансплантации гемопоэтических стволовых клеток</institution><country>Италия</country></aff><aff xml:lang="en"><institution>Hematology and HSC Transplant Center</institution><country>Italy</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Областная больница Сан Карло, Отделение сердечной хирургии и сердечно-сосудистой интенсивной терапии</institution><country>Италия</country></aff><aff xml:lang="en"><institution>Department of Cardiac Surgery and Cardiovascular Intensive Care Azienda Ospedaliera Regionale San Carlo</institution><country>Italy</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>29</day><month>04</month><year>2021</year></pub-date><volume>17</volume><issue>2</issue><fpage>27</fpage><lpage>36</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Амендола А., Патерностер Д., Паскале С.П., Нуккорини Р., Д'Амора М., Питтелла Д., Д'Асколи Р., Престипино Ф., Луци Д., Пиццути М., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Амендола А., Патерностер Д., Паскале С.П., Нуккорини Р., Д'Амора М., Питтелла Д., Д'Асколи Р., Престипино Ф., Луци Д., Пиццути М.</copyright-holder><copyright-holder xml:lang="en">Amendola A., Paternoster G., Pascale S.P., Nuccorini R., D'Amora M., Pittella G., D'Ascoli R., Prestipino F., Luzi G., Pizzuti M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.reanimatology.com/rmt/article/view/2050">https://www.reanimatology.com/rmt/article/view/2050</self-uri><abstract><p>Пароксизмальная ночная гемоглобинурия (ПНГ) — клональное заболевание гемопоэтических стволовых клеток, которое проявляется гемолитической анемией, тромбозами и недостаточностью функции костного мозга. Пациент мужского пола 51 года с ПНГ в анамнезе, по поводу которой он получал лечение экулизумабом, поступил в больницу с жалобами на острую боль в грудной клетке и одышку. Поставили диагноз трехсосудистого поражения коронарного русла, по поводу чего запланировали проведение аортокоронарного шунтирования. Для того, чтобы избежать развития как тромбоза, так и кровотечения, в данном сложном клиническом случае, решили провести пациенту тромбоэластографическое исследование и использовать параметр R в качестве целевого при проведении антикоагулянтной терапии. При поддержании значений данного параметра в рамках 11-14 сек можно достичь оптимального баланса между риском тромбоза и кровотечения. Кроме того, во время оперативного вмешательства не наблюдали острого гемолиза, а для уменьшения риска развития внутрисосудистого гемолиза дополнительно назначили экулизумаб.</p></abstract><trans-abstract xml:lang="en"><p>Paroxysmal nocturnal haemoglobinuria (PNH) is a clonal haematopoietic stem cell disease that presents with haemolytic anaemia, thrombosis and bone marrow failure. We report a case of a 51-year-old male with a history of PNH in treatment with Eculizumab admitted to our Hospital for acute chest pain and dyspnoea. The diagnosis was a triple vessel disease and patient was scheduled for coronary artery bypass grafting surgery. To balance the risk between thrombosis and bleeding in this particular clinical setting, we decided to use thromboelastography (TEG) as point of care solution and we used the R parameter as the target of our anticoagulant therapy. The R parameter between 11 and 14 sec can be used as a target value to balance the risk; in addition, there was no evidence of acute hemolysis during the surgery and supplemental dose of Eculizumab was administered in order to minimize any potential exacerbation of intravascular hemolysis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>пароксизмальная ночная гемоглобинурия</kwd><kwd>экулизумаб</kwd><kwd>тромбоэластограмма</kwd></kwd-group><kwd-group xml:lang="en"><kwd>paroxysmal nocturnal haemoglobinuria</kwd><kwd>eculizumab</kwd><kwd>thromboelastogram</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Brodsky R.A. Paroxysmal nocturnal hemoglobinuria. Blood. 2014: 30; 124 (18): 2804-2811. PMID: 25237200 PMCID: PMC4215311. DOI: 10.1182/blood-2014-02-522128</mixed-citation><mixed-citation xml:lang="en">Brodsky R.A. Paroxysmal nocturnal hemoglobinuria. Blood. 2014: 30; 124 (18): 2804-2811. PMID: 25237200 PMCID: PMC4215311. DOI: 10.1182/blood-2014-02-522128</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Schrezenmeier H., Muus P, Socie G., Szer J., Urbano-Ispizua A., Ma-ciejewski J.P., Brodsky R.A., Bessler M., Kanakura Y., Wendell Rosse W., Khursigara G., Bedrosian C., Hillmen P. Baseline characteristics and disease burden in patients in the international paroxysmal nocturnal hemoglobinuria registry. Haematologica. 2014; 99 (5): 922-929. PMID: 24488565 PMCID: PMC4008114. DOI: 10.3324/haematol.2013.093161</mixed-citation><mixed-citation xml:lang="en">Schrezenmeier H., Muus P, Socie G., Szer J., Urbano-Ispizua A., Ma-ciejewski J.P., Brodsky R.A., Bessler M., Kanakura Y., Wendell Rosse W., Khursigara G., Bedrosian C., Hillmen P. Baseline characteristics and disease burden in patients in the international paroxysmal nocturnal hemoglobinuria registry. Haematologica. 2014; 99 (5): 922-929. PMID: 24488565 PMCID: PMC4008114. DOI: 10.3324/haematol.2013.093161</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lima M. Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry. Pract Lab Med. 2020; 20: e00158. PMID: 32195308 PMCID: PMC7078534. DOI: 10.1016/j.plabm.2020.e00158</mixed-citation><mixed-citation xml:lang="en">Lima M. Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry. Pract Lab Med. 2020; 20: e00158. PMID: 32195308 PMCID: PMC7078534. DOI: 10.1016/j.plabm.2020.e00158</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Socie G., Varoqueaux N., Peffault de Latour R. Eculizumab in Paroxysmal nocturnal hemoglobinuria. Med Sci (Paris). 2009; 25 (12): 126-9. PMID: 20035691. DOI: 10.1051/medsci/200925121126</mixed-citation><mixed-citation xml:lang="en">Socie G., Varoqueaux N., Peffault de Latour R. Eculizumab in Paroxysmal nocturnal hemoglobinuria. Med Sci (Paris). 2009; 25 (12): 126-9. PMID: 20035691. DOI: 10.1051/medsci/200925121126</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Griffin M., Munir T. Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide. Ther Adv Hematol. 2017; 8 (3): 119-126. PMID: 28246555 PMCID: PMC5305005. DOI: 10.1177/2040620716681748</mixed-citation><mixed-citation xml:lang="en">Griffin M., Munir T. Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide. Ther Adv Hematol. 2017; 8 (3): 119-126. PMID: 28246555 PMCID: PMC5305005. DOI: 10.1177/2040620716681748</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kang K.-W., Moon H., Lee B.-H., Jeon M.-J., Yu E.S., Kim D.-S., Lee S.-R., Sung H.-J., Choi C.-W., Kim B.-S., Lee J.-Y., Park Y. Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab. Ann Hematol. 2020; 99 (7): 1493-1503. PMID: 32542443. DOI: 10.1007/s00277-020-04133-z</mixed-citation><mixed-citation xml:lang="en">Kang K.-W., Moon H., Lee B.-H., Jeon M.-J., Yu E.S., Kim D.-S., Lee S.-R., Sung H.-J., Choi C.-W., Kim B.-S., Lee J.-Y., Park Y. Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab. Ann Hematol. 2020; 99 (7): 1493-1503. PMID: 32542443. DOI: 10.1007/s00277-020-04133-z</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Röth A., Araten D.J., Larratt L., Kulasekararaj A.J., Maciejewski J.P., Wilson A., Gustovic P., Kanakura Y. Beneﬁcial eﬀects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International Paroxysmal Nocturnal Hemoglobinuria Registry. Eur J Haematol. 2020; 105 (5): 561–570. PMID: 32640047. DOI: 10.1111/ejh.13485</mixed-citation><mixed-citation xml:lang="en">Röth A., Araten D.J., Larratt L., Kulasekararaj A.J., Maciejewski J.P., Wilson A., Gustovic P., Kanakura Y. Beneﬁcial eﬀects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International Paroxysmal Nocturnal Hemoglobinuria Registry. Eur J Haematol. 2020; 105 (5): 561–570. PMID: 32640047. DOI: 10.1111/ejh.13485</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Villegas A., Arrizabalaga B., Bonanad S., Colado E., Gaya A.M., Ataúlfo González F., Jarque I., Núñez R., Ojeda E., Orfao A., Ribera Santasusana J.M., Ortega V.V., Ispizua A.U. Consenso español para el diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Medicina Clínica. 2016; 146 (6): 278.e1–278.e7. DOI: 10.1016/j.medcli.2015.12.012</mixed-citation><mixed-citation xml:lang="en">Villegas A., Arrizabalaga B., Bonanad S., Colado E., Gaya A.M., Ataúlfo González F., Jarque I., Núñez R., Ojeda E., Orfao A., Ribera Santasusana J.M., Ortega V.V., Ispizua A.U. Consenso español para el diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Medicina Clínica. 2016; 146 (6): 278.e1–278.e7. DOI: 10.1016/j.medcli.2015.12.012</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cançado R.D., Araújo A da S., Sandes A.F., Arrais C., Lopes De Castro Lobo C., Figueiredo M.S., Menosi Gualandro S.F., Olalla Saad S.T., Ferreira Costa F. Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. Hematology, Transfusion and Cell Therapy. Published online July 2020: S2531137920300791. DOI: 10.1016/j.htct.2020.06.006</mixed-citation><mixed-citation xml:lang="en">Cançado R.D., Araújo A da S., Sandes A.F., Arrais C., Lopes De Castro Lobo C., Figueiredo M.S., Menosi Gualandro S.F., Olalla Saad S.T., Ferreira Costa F. Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. Hematology, Transfusion and Cell Therapy. Published online July 2020: S2531137920300791. DOI: 10.1016/j.htct.2020.06.006</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">van Bijnen S.T.A., Vermeer H., Mourisse J.M.J., de Witte T., van Swieten H.A., Muus P. Cardiopulmonary bypass in a patient with classic paroxysmal nocturnal hemoglobinuria during treatment with eculizumab: Letter to the Editor. European Journal of Haematology. 2011; 87 (4): 376–378. PMID: 21623921. DOI: 10.1111/j.16000609.2011.01656.x</mixed-citation><mixed-citation xml:lang="en">van Bijnen S.T.A., Vermeer H., Mourisse J.M.J., de Witte T., van Swieten H.A., Muus P. Cardiopulmonary bypass in a patient with classic paroxysmal nocturnal hemoglobinuria during treatment with eculizumab: Letter to the Editor. European Journal of Haematology. 2011; 87 (4): 376–378. PMID: 21623921. DOI: 10.1111/j.16000609.2011.01656.x</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pape L., Hartmann H., Bange F.C., Suerbaum S., Bueltmann E., Ahlenstiel-Grunow T. Eculizumab in typical hemolytic uremic syndrome (Hus) with neurological involvement. Medicine. 2015; 94 (24): e1000. PMID: 26091445 PMCID: PMC4616562. DOI: 10.1097/MD.0000000000001000</mixed-citation><mixed-citation xml:lang="en">Pape L., Hartmann H., Bange F.C., Suerbaum S., Bueltmann E., Ahlenstiel-Grunow T. Eculizumab in typical hemolytic uremic syndrome (Hus) with neurological involvement. Medicine. 2015; 94 (24): e1000. PMID: 26091445 PMCID: PMC4616562. DOI: 10.1097/MD.0000000000001000</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gross O. Eculizumab end ECMO rescue therapy of most severe ARDS in a young boy with goodpasture's syndrome. In: Proceedings from ASN Kidney Week. New Orleans, LA; 2017: A THPO439</mixed-citation><mixed-citation xml:lang="en">Gross O. Eculizumab end ECMO rescue therapy of most severe ARDS in a young boy with goodpasture's syndrome. In: Proceedings from ASN Kidney Week. New Orleans, LA; 2017: A THPO439</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Neumann F-J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J.-P, Falk V, Head S.J., Juni P, Kastrati A., Koller A., Kristensen S.D., Niebauer J., Richter D.J., Seferovic P.M., Sibbing D., Stefanini G.G., Windecker S., Yadav R., Zembala M.O., ESC Scientific Document Group. 2018 ESC/EACTS guidelines on myocardial revascularization. European Heart Journal. 2019; 40 (2): 87-165. PMID: 30165437. DOI: 10.1093/eurheartj/ehy394</mixed-citation><mixed-citation xml:lang="en">Neumann F-J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J.-P, Falk V, Head S.J., Juni P, Kastrati A., Koller A., Kristensen S.D., Niebauer J., Richter D.J., Seferovic P.M., Sibbing D., Stefanini G.G., Windecker S., Yadav R., Zembala M.O., ESC Scientific Document Group. 2018 ESC/EACTS guidelines on myocardial revascularization. European Heart Journal. 2019; 40 (2): 87-165. PMID: 30165437. DOI: 10.1093/eurheartj/ehy394</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Patel M.R., Dehmer G.J., Grantham J.A., Maddox T.M., Maron D.J., Smith P.K. Calhoon J.H., ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease. Journal of the American College of Cardiology. 2017; 69 (17): 2212-2241. PMID: 28291663. DOI: 10.1016/j.jacc.2017.02.001</mixed-citation><mixed-citation xml:lang="en">Patel M.R., Dehmer G.J., Grantham J.A., Maddox T.M., Maron D.J., Smith P.K. Calhoon J.H., ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease. Journal of the American College of Cardiology. 2017; 69 (17): 2212-2241. PMID: 28291663. DOI: 10.1016/j.jacc.2017.02.001</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mannacio V., Di Tommaso L., De Amicis V., Stassano P., Vosa C. Randomized flow capacity comparison of skeletonized and pedicled left internal mammary artery. The Annals of Thoracic Surgery. 2011; 91 (1): 24–30. PMID: 21172479. DOI: 10.1016/j.athoracsur.2010.06.131</mixed-citation><mixed-citation xml:lang="en">Mannacio V., Di Tommaso L., De Amicis V., Stassano P., Vosa C. Randomized flow capacity comparison of skeletonized and pedicled left internal mammary artery. The Annals of Thoracic Surgery. 2011; 91 (1): 24–30. PMID: 21172479. DOI: 10.1016/j.athoracsur.2010.06.131</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Guru V. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation. 2006; 114 (1_suppl): I-331I-338. PMID: 16820596. DOI: 10.1161/CIRCULATIONAHA.105.001644</mixed-citation><mixed-citation xml:lang="en">Guru V. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation. 2006; 114 (1_suppl): I-331I-338. PMID: 16820596. DOI: 10.1161/CIRCULATIONAHA.105.001644</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Raja S.G. Surgical strategies for bilateral internal mammary artery grafting. International Journal of Surgery. 2015; 16: 140–145. PMID: 25463040. DOI: 10.1016/j.ijsu.2014.11.006</mixed-citation><mixed-citation xml:lang="en">Raja S.G. Surgical strategies for bilateral internal mammary artery grafting. International Journal of Surgery. 2015; 16: 140–145. PMID: 25463040. DOI: 10.1016/j.ijsu.2014.11.006</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Dias J.D., Sauaia A., Achneck H.E., Hartmann J., Moore E.E. Thromboelastography‐guided therapy improves patient blood management and certain clinical outcomes in elective cardiac and liver surgery and emergency resuscitation: A systematic review and analysis. J Thromb Haemost. 2019; 17 (6): 984–994. PMID: 30947389 PMCID: PMC6852204. DOI: 10.1111/jth.14447</mixed-citation><mixed-citation xml:lang="en">Dias J.D., Sauaia A., Achneck H.E., Hartmann J., Moore E.E. Thromboelastography‐guided therapy improves patient blood management and certain clinical outcomes in elective cardiac and liver surgery and emergency resuscitation: A systematic review and analysis. J Thromb Haemost. 2019; 17 (6): 984–994. PMID: 30947389 PMCID: PMC6852204. DOI: 10.1111/jth.14447</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Nakayama Y., Nakajima Y., Tanaka K.A., Sessler D.I., Maeda S., Iida J., Ogawa S., Mizobe T. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth. 2015; 114 (1): 91–102. PMID: 25303988. DOI: 10.1093/bja/aeu339</mixed-citation><mixed-citation xml:lang="en">Nakayama Y., Nakajima Y., Tanaka K.A., Sessler D.I., Maeda S., Iida J., Ogawa S., Mizobe T. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth. 2015; 114 (1): 91–102. PMID: 25303988. DOI: 10.1093/bja/aeu339</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
